Press Releases

Find out the latest announcements and updates from Genialis. This is where you’ll find newest reports on our partnerships, collaborations, and achievements.

April 23, 2025|
Genialis Highlights Power of its Supermodel to Predict and Explain Therapeutic Response at AACR 2025
January 28, 2025|
Genialis Advances Biomarker Discovery to Reduce Risk in Cancer Drug Development Targeting DNA Damage Response Pathways
January 8, 2025|
Tempus Announces a Collaboration With Genialis to Develop RNA-Based Biomarker Algorithms
November 8, 2024|
Genialis Highlights Potential of Xerna TME Panel as a Predictive Biomarker in Poster at SITC 39th Annual Meeting
September 25, 2024|
Genialis Launches First-in-Class Biomarker to Predict Tumor Response and Clinical Benefit to KRAS Inhibitors
September 4, 2024|
Genialis Named Finalist for Biotech Innovation Award at Biotech Week Boston
July 24, 2024|
RNA Biomarker Company Genialis Attends BIO Asia to Grow Collaborations in Taiwan
June 12, 2024|
Pharma Oncology Development Veteran Krista McKerracher Named Chairperson of the Board for Genialis
May 31, 2024|
Genialis and Pancreatic Cancer Action Network (PanCAN) Partner to Progress KRAS Diagnostics

Media Kit

Boilerplate

Genialis, the RNA biomarker company, is creating a world where healthcare delivers the best possible outcomes for patients, their families, and their communities. Genialis develops and validates clinically actionable biomarkers informed by the world’s most ethnographically diverse cancer data sets to better predict patient responses and guide treatment decisions for targeted inhibitors, immunotherapies, and other emerging therapeutic classes. Genialis is trusted by pharma and diagnostics partners, and together, we are revolutionizing precision oncology with RNA and AI.

Links & Downloads

Leadership Headshots

Talking Precision Medicine Info Sheet

Leadership Team

linkedin.com/company/genialis

Media Contact

Andrea Vuturo
Vuturo Group for Genialis
andrea@vuturo.com
+1-415-689-8414

Genialis Highlights Power of its Supermodel to Predict and Explain Therapeutic Response at AACR 2025. Read the press release →

Genialis Highlights Power of its Supermodel to Predict and Explain Therapeutic Response at AACR 2025. Read the press release → Genialis Highlights Power of its Supermodel to Predict and Explain Therapeutic Response at AACR 2025. Read the press release →

This website uses cookies and third party services. Read More Accept Reject